AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NOVO RESOURCES CORP-CDI

0.105

-0.010-8.70%

Volume:345.32K

Turnover:36.84K

Market Cap:37.24M

PE:-1.42

High:0.110

Open:0.110

Low:0.105

Close:0.115

Loading ...

Overview Company News Filings

Novo Resources To Conduct Aircore Drilling Program at Western Australia Project

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

MT Newswires Live

Aircore Drilling to Commence at Balla Balla

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading

MT Newswires Live

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires Live

Top Midday Stories: Novo Nordisk Shares Fall After Weight-Loss Drug Trial Results; Rocket to Acquire Redfin for $1.75 Billion

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading

MT Newswires Live

Stock Market Today: Dow Jones Dives After Trump Says This On Recession; Palantir Plunges, Nears 37% Decline (Live Coverage)

Novo Nordisk Dives 8%. Why Eli Lilly Now Has The Upper Hand.

5 Things to Know Before the Stock Market Opens

Novo Nordisk's CagriSema Meets Primary Endpoint in Phase 3 Trial

MT Newswires Live

Market Chatter: CDC Plans Study on Potential Vaccine, Autism Connections

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT Newswires Live

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

MT Newswires Live

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires Live

Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health

Novo Nordisk Launches Delivery Option Offering Lower-Priced Wegovy

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVO.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","market":"AU","secType":"STK","nameCN":"NOVO RESOURCES CORP-CDI","latestPrice":0.105,"timestamp":1746079920000,"preClose":0.115,"halted":0,"volume":345315,"delay":0,"nameEN":"NOVO RESOURCES CORP-CDI","floatShares":314709406,"shares":354630279,"eps":-0.0741907568675276,"marketStatus":"Not Yet Opened","change":-0.01,"latestTime":"05-01 16:12:00 AEST","open":0.11,"high":0.11,"low":0.105,"amount":36843,"amplitude":0.043478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0741907568675276,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":0,"adr":0,"adrRate":1,"listingDate":1694268000000,"exchange":"ASX","adjPreClose":0.115,"openAndCloseTimeList":[[1746057600000,1746079200000]],"volumeRatio":1.2492927134268412,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","floatShares":314709406,"roa":"-13.14%","roe":"-30.09%","lyrEps":-0.074191,"volumeRatio":1.2492927134268412,"shares":354630279,"dividePrice":0,"high":0.11,"amplitude":0.043478,"preClose":0.115,"low":0.105,"week52Low":0.081,"pbRate":"0.47","psRate":"13.19","week52High":0.16,"institutionHeld":0,"latestPrice":0.105,"eps":-0.0741907568675276,"divideRate":0,"volume":345315,"delay":0,"ttmEps":-0.0741907568675276,"open":0.11,"prevYearClose":0.094,"prevWeekClose":0.12,"prevMonthClose":0.115,"prevQuarterClose":0.098,"fiveDayClose":0.1,"twentyDayClose":0.098,"sixtyDayClose":0.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVO.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520914580","title":"Novo Resources To Conduct Aircore Drilling Program at Western Australia Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2520914580","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520914580?lang=en_us&edition=fundamental","pubTime":"2025-03-20 09:16","pubTimestamp":1742433417,"startTime":"0","endTime":"0","summary":"Novo Resources  said that a maiden air core drill program to test priority targets at the Balla Balla gold project in Western Australia is expected to start in late March, according to a Thursday Australian bourse filing.The program will test below shallow cover and its commencement will depend on the weather. Several prospects have been identified for drill testing including Ramquarry, Cockerell, Babbage, and Beaufort.Mapping and sampling campaigns were completed at the Tibooburra and John Bull gold projects in New South Wales, improving the geological interpretation and understanding of controls on mineralization. Assay results are being received for both projects, the filing said.Reverse circulation drilling at both New South Wales projects is expected to start in the second quarter.Its shares fell 1% in early trading on Thursday.Price : $0.10, Change: $-0.0010, Percent Change: -1.03%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","XAO.AU","BK7104","BK4168","XKO.AU","XJO.AU","WRN"],"gpt_icon":0},{"id":"2520813070","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2520813070","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520813070?lang=en_us&edition=fundamental","pubTime":"2025-03-19 23:03","pubTimestamp":1742396608,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Wednesday morning, declining 0.36% to 1,442.32 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and internet browser company Opera , which rose 3.6% each. They were followed by 3D printer company Materialise  and petroleum refiner Equinor , which were up 2.2% and 1.9% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and financial services company Banco Bilbao Vizcaya Argentaria , which fell 2.5% and 2.1% respectively. They were followed by pharmaceutical companies Ascendis Pharma  and Novo Nordisk , which were down 1.8% and 1.3% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals  and Akari Therapeutics , which advanced 25% and 5% respectively. They were followed by biopharmaceutical company Amarin  and cru","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NCNA","GSK.UK","LU0320765992.SGD","LU0889565916.HKD","MTLS","EQNR","BK4599","LU0109394709.USD","LU1093756168.USD","BK4107","AFG","BK4532","BBVA","ASND","BK4023","BK4585","GSK","IE00BZ1G4Q59.USD","BK4007","LU0154236417.USD","TRIB","BK4141","BK4082","BK4207","LU1829250122.USD","AKTX","BK4588","NVO.AU","BK4117","BK7104","BK4546","BK4139","SNN","BK4142","BK4201","BDRX","CUK","LU1093756325.SGD","SQNS","OPRA","IE00BKVL7J92.USD","DBVT","AMRN"],"gpt_icon":1},{"id":"2520180284","title":"Aircore Drilling to Commence at Balla Balla","url":"https://stock-news.laohu8.com/highlight/detail?id=2520180284","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520180284?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:58","pubTimestamp":1742389080,"startTime":"0","endTime":"0","summary":"Aircore drilling to test priority targets expected to commence in late-March, weather dependent, at the Balla Balla Gold Project.Drilling is planned to target zones of structural complexity and splay faults proximal to the Sholl Shear Zone, under generally shallow cover.The Sholl Shear Zone is a fertile, long lived, crustal-scale feature which trends over 200 km in the northern Pilbara.Geological interpretation has identified folded and offset mafic and ultramafic stratigraphy in complex zones around splays off the Sholl Shear Zone.Several prospects are delineated for drill testing including Ramquarry, Cockerell, Babbage and Beaufort.Mapping and sampling campaigns completed at the Tibooburra and John Bull Gold Projects in NSW.Figure 1: Novo Tenure in the Central Pilbara showing major structural architecture, priority prospects and the location of the Balla Balla Gold Project. The Sholl Shear Zone is a significant geological feature extending for more than 200 km along the northwest coa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aircore-drilling-commence-balla-balla-125800124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["NSRPF","BK7095","NVO.AU","XAO.AU","DEG.AU","PLS.AU","AC","BK7507","BK4135","BK7506","BK4017","BK7104","XKO.AU","XJO.AU","BK7504","MRE.AU"],"gpt_icon":0},{"id":"2520757405","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2520757405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520757405?lang=en_us&edition=fundamental","pubTime":"2025-03-17 23:00","pubTimestamp":1742223615,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 1.12% to 1,433.84 on the S&P Europe Select ADR Index.From continental Europe, ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRIB","BK4142","CUK","LU1093756168.USD","BCYC","AMRN","CLLS","BK7104","BK4585","LU0889565916.HKD","LU1093756325.SGD","AFG","BK4077","DAVA.AU","ASND","BK4117","BK4141","LU0109394709.USD","AKTX","LU0084288595.USD","BK4107","NVO.AU","BK4082","BK4009","BK4007","BK4532","IE00BKVL7J92.USD","VRNA","IE00BFMHRM44.USD","BK4134","DBVT","IE00BZ1G4Q59.USD","NVO","BK4599","LU0648005311.SGD","PUK","SQNS","CRTO","BK4588","DAVA","TRVG","BK4139","LU0154236417.USD","EDAP","BK4162","LU0320765992.SGD"],"gpt_icon":1},{"id":"2519855800","title":"European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2519855800","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519855800?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:09","pubTimestamp":1741878554,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were treading water late Thursday morning, edging 0.1% higher to 1,396.7 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS  and pharmaceutical company Novo Nordisk , which rose 4.7% and 3.3% respectively. They were followed by pharmaceutical company Ascendis Pharma  and telecommunications operator Telefonica , which were up 1.7% and 1.5% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and software firm SAP , which fell 2.7% and 2.3% respectively. They were followed by biotechnology companies argenx  and Evaxion Biotech , which dropped 2.1% and 0.9% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics  and telecommunications operator Vodafone Group , which increased 5.2% and 3% respectively. They were followed by pharmaceutical companies Amari","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AFG","BK4505","BK4532","NCNA","BK4007","NVO.AU","LU2456880835.USD","AMRN","SAP","BK4521","BK4599","LU2417539215.USD","EVAX","BK4139","BK4115","AKTX","LU0320765992.SGD","BK4141","BK4207","BK7104","IE00BKVL7J92.USD","NVO","LU1093756168.USD","LU0154236417.USD","VOD","BK4585","AZN","BK4588","TEF","IE00BZ1G4Q59.USD","BK4132","LU2462157665.USD","EDAP","LU1829250122.USD","BCS","LU0109394709.USD","BK4107","ASND","SLN","BK4568","LU2236285917.USD","SQNS","ARGX","BK4117","BK4023","BK4528","LU0889565916.HKD","TCBP","BK4613","LU1093756325.SGD"],"gpt_icon":1},{"id":"2518062205","title":"Sector Update: Health Care Stocks Decline Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2518062205","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518062205?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:02","pubTimestamp":1741629771,"startTime":"0","endTime":"0","summary":"Health care stocks were lower Monday afternoon, with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.1%.The iShares Biotechnology ETF (IBB) retreated ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","IE00BZ1G4Q59.USD","BK4581","NVO","LU1093756325.SGD","LU0154236417.USD","BK4548","IBB","BK4139","BK4585","BK4535","XLV","IE00BKVL7J92.USD","BK4532","BK4599","LU1093756168.USD","BNTX","BK4568","BK7104","BK4551","BK4007","CKPT","BK4588"],"gpt_icon":1},{"id":"2518274278","title":"Top Midday Stories: Novo Nordisk Shares Fall After Weight-Loss Drug Trial Results; Rocket to Acquire Redfin for $1.75 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274278","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518274278?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:46","pubTimestamp":1741621619,"startTime":"0","endTime":"0","summary":"All three major market US stock indexes were in the red in late-morning trading Monday, with the Nasdaq Composite leading the way down, as investors continue to fret over the state of the US economy a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1989764748.USD","BK4504","BK4195","BK4547","LU1267930730.SGD","NOW","LU0353189763.USD","BK4534","RDFN","BK4555","LU1989772923.USD","RKT","BK4566","LU0208291251.USD","F","LU2286300806.USD","CVS.AU","IE00B19Z9P08.USD","LU2125909247.SGD","LU0820561909.HKD","LU0265550359.USD","LU2264538146.SGD","LU0265550946.USD","LU2106854487.HKD","LU0006061336.USD","LU1951198990.SGD","LU0320765489.SGD","NVO","LU1923622291.USD","IE00BSNM7G36.USD","CVS","BK4585","LU0820561818.USD","BK4532","LU0081259029.USD","LU0672654240.SGD","NVO.AU","RKT.AU","LU2125909593.SGD","LU0719512351.SGD","LU0072461881.USD","BK4196","LU0082616367.USD","LU1551013342.USD","BK4608","LU1093756325.SGD","LU0109391861.USD","BK4229","BK4007","BK4516"],"gpt_icon":1},{"id":"2518027902","title":"European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2518027902","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518027902?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:20","pubTimestamp":1741620049,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were falling late Monday morning, dropping 2.31% on the S&P Europe Select ADR Index to 1,411.83.From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies  and petroleum refiner Equinor , which rose 6.4% and 5.1%, respectively. They were followed by medical device maker EDAP TMS  and consumer goods giant Unilever , which were up 4.8% and 3.1%, respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and financial services company Banco Santander , which fell 10% and 5.7%, respectively. They were followed by biotech firm Evaxion Biotech  and internet browser company Opera , which were down 5.3% each.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and utilities company National Grid , which advanced 11% and 2.8%, respectively. They were followed by biopharmaceutical company TC Biopharm  and oil a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4183","NVO","BK4599","BK4521","NGG","TCBP","LU1162221912.USD","SAN.AU","AKTX","LU0154236417.USD","BK4585","LU0072461881.USD","BK4082","BK7104","UL","BK4592","UN","BCS","EQNR","AFG","BP","BK4588","LU0124676726.USD","BK4532","BK4142","LU1093756168.USD","NVO.AU","BK7142","EDAP","LU0689626769.HKD","BK4207","BK4208","IE00BZ1G4Q59.USD","BDRX","ULVR.UK","EVAX","BK4107","CUK","SAN","IE00BKVL7J92.USD","OPRA","BK4201","LU0162691827.USD","LU1093756325.SGD","BK4023","LU0320765646.SGD","VRNA","BK4007","BK4117","DBVT"],"gpt_icon":1},{"id":"2518583272","title":"Stock Market Today: Dow Jones Dives After Trump Says This On Recession; Palantir Plunges, Nears 37% Decline (Live Coverage)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518583272","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518583272?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:59","pubTimestamp":1741618761,"startTime":"0","endTime":"0","summary":"The Dow Jones plunged on the stock market today after President Donald Trump spoke about recession and tariffs. Tesla and Palantir took a dive.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2021/10/Stock-redtrump-03-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2021/10/Stock-redtrump-03-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/market-trend/stock-market-today/dow-jones-dives-nasdaq-sp500-trump-recession-palantir-pltr-nvidia-nvda-tesla-tsla/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["3NVD.UK","PLTR","NVD2.UK","LU0724617625.USD","2NVD.UK","NVIW.SI","SNVD.UK","LU0861579265.USD","LU2077746001.SGD","LU2471134879.HKD","LU1496350171.SGD","LU1066051811.HKD","LU2249611893.SGD","LU0109391861.USD","LU1037948897.HKD","LU2125154778.USD","NVDU","NVD3.UK","IE00B7KXQ091.USD","NVDD","IE0004086264.USD","LU2756315318.SGD","LU0823414478.USD","NVO.AU","LU0234572021.USD","IE0004445015.USD","IE00B775H168.HKD","SGXZ99366536.SGD","LU0175139822.USD","NVDY","IE00BJTD4V19.USD","LU0788109477.HKD","LU1861127337.USD","TSYW.SI","IE00B5949003.HKD","NVDS","NVDS.UK","NVD","IE00BJJMRY28.SGD","LU1923622614.USD","IE00BQXX3C00.GBP","BK4550","LU2463028550.USD","LU2108987350.USD","LU0061474705.USD"],"gpt_icon":0},{"id":"2518302224","title":"Novo Nordisk Dives 8%. Why Eli Lilly Now Has The Upper Hand.","url":"https://stock-news.laohu8.com/highlight/detail?id=2518302224","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518302224?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:06","pubTimestamp":1741611979,"startTime":"0","endTime":"0","summary":"Novo Nordisk stock tumbled Monday after its experimental weight-loss drug failed to top its rival from Eli Lilly in a Phase 3 study.","market":"fut","thumbnail":"https://www.investors.com/wp-content/uploads/2024/02/Stock-novonordisk-building-03-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/02/Stock-novonordisk-building-03-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/novo-nordisk-stock-weight-loss-drug-cagrisema-zepbound/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU2063271972.USD","LU0094547139.USD","LU0114720955.EUR","LU0456855351.SGD","LU0882574139.USD","BK4007","LU0471298777.SGD","LU1127390331.HKD","LU2089984988.USD","BK4581","SG9999014914.USD","LU1720051108.HKD","LU0203201768.USD","SGXZ57979304.SGD","LU0385154629.USD","LU1983299246.USD","LU2237443978.SGD","NVO.AU","IE00BJLML261.HKD","LU2361044949.HKD","LU1814569148.SGD","LU0256863811.USD","LU2491050071.SGD","LU2357305700.SGD","LLY","LU1623119135.USD","LU1061106388.HKD","LU1366192091.USD","LU2264538146.SGD","SG9999014898.SGD","LU2112291526.USD","LU0154236417.USD","BK7104","IE0004445239.USD","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","NVO","LU0689472784.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","LU1069344957.HKD","LU1804176565.USD","LU0354030511.USD","LU0061475181.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU0943347566.SGD","LU2491050154.USD","IE00BJT1NW94.SGD","LU1280957306.USD"],"gpt_icon":1},{"id":"2518226113","title":"5 Things to Know Before the Stock Market Opens","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226113","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226113?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:00","pubTimestamp":1741608046,"startTime":"0","endTime":"0","summary":"U.S. stock futures point lower after a volatile week of trading and President Donald Trump's comments from a weekend interview in which he failed to rule out a recession; Oracle  shares are declining ahead of the cloud services giant's third-quarter earnings after the bell; Redfin  shares soar 75% on news the digital real estate brokerage is being acquired by Rocket Companies  for $1.75 billion of equity value; and U.S.-listed shares of Novo Nordisk  are falling after the latest trial results of its CagriSema weight-loss drug. Here's what investors need to know today.Redfin  shares are jumping 75% on news the digital real estate brokerage is being acquired by Rocket Companies  for $1.75 billion. Rocket shares are sinking 11% after the Detroit-based mortgage lender said it was buying Redfin in an all-stock transaction for $12.50 per share. \"Together, we will improve the experience by connecting traditionally disparate steps of the search and financing process with leading technology tha","market":"sg","thumbnail":"https://www.investopedia.com/thmb/n-SyAfYIP_mfcNDBCjSbdp2dNeU=/800x533/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2202870636-a9d6af654d94457dac5eee63cd2d0d4c.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/n-SyAfYIP_mfcNDBCjSbdp2dNeU=/800x533/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2202870636-a9d6af654d94457dac5eee63cd2d0d4c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/5-things-to-know-before-the-stock-market-opens-march-10-2025-11693783","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["BK4534","LU0234570918.USD","LU0433182093.SGD","BK4229","LU0444973449.USD","LU1201861249.SGD","LU0648001328.SGD","LU0878866978.SGD","LU0056508442.USD","LU0965509101.SGD","LU0719512351.SGD","LU0323591593.USD","BK4548","IE00BBT3K403.USD","BK7084","IE00BLSP4239.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4588","IE00B19Z3581.USD","LU0861579265.USD","LU1429558221.USD","BK4195","LU1934455194.USD","ORCL","LU1935042991.SGD","LU1934455863.HKD","RDFN","LU1435385759.SGD","LU0068578508.USD","LU2236285917.USD","BK4532","LU0957808578.USD","RKT","LU1935042488.USD","NVO.AU","BK4543","LU0320765489.SGD","LU0256863811.USD","IE00BZ1G4Q59.USD","BK4538","LU0154236417.USD","LU1366333091.USD","LU1815336760.USD","NVO","RKT.AU","LU2054465674.USD","LU0965509010.AUD","LU1035773651.USD"],"gpt_icon":1},{"id":"2518409192","title":"Novo Nordisk's CagriSema Meets Primary Endpoint in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2518409192","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518409192?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:43","pubTimestamp":1741607039,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Monday that its phase 3 trial evaluating CagriSema -- a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg --met its primary endpoint in 1,206 overweight or obese patients with type 2 diabetes.The trial showed a \"statistically significant and superior weight loss\" with CagriSema compared to placebo at week 68. Patients on CagriSema achieved a 15.7% weight loss, versus 3.1% in the placebo group, the company said.Additionally, 89.7% of CagriSema-treated patients achieved at least 5% weight loss, which was a co-primary endpoint, compared with 30.3% with placebo.Novo Nordisk said CagriSema was well-tolerated, with mostly mild to moderate gastrointestinal side effects.The company plans to seek regulatory approval in Q1 2026.Novo Nordisk shares were down more than 5% in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","LU0154236417.USD","BK4532","BK4588","BK7104","LU1093756325.SGD","NVO.AU","IE00BKVL7J92.USD","BK4007","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","BK4585"],"gpt_icon":1},{"id":"2517554174","title":"Market Chatter: CDC Plans Study on Potential Vaccine, Autism Connections","url":"https://stock-news.laohu8.com/highlight/detail?id=2517554174","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517554174?lang=en_us&edition=fundamental","pubTime":"2025-03-08 01:27","pubTimestamp":1741368447,"startTime":"0","endTime":"0","summary":"The US Centers for Disease Control and Prevention plans to conduct a large study into the potential relationship between vaccines and autism, Reuters reported Friday, citing two sources familiar with the matter.Reuters said the planned study comes amid the ongoing measles outbreak in the US, which was possibly intensified by declining vaccinations in certain parts of the country.The US Centers for Disease Control and Prevention did not immediately respond to MT Newswires' request for comment.Shares of Eli Lilly , Novo Nordisk  were down in recent trading, while Moderna  and Johnson & Johnson  were recently higher.Price: 865.15, Change: -47.61, Percent Change: -5.22","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BDGV0183.EUR","LU1221951129.SGD","LU0708995401.HKD","LU1917777945.USD","LU0345769128.USD","IE00B19Z3581.USD","LU1035775433.USD","LU1914381329.SGD","LU1974910355.USD","LU0058720904.USD","LU2211815571.USD","IE00BK4W5L77.USD","LU0943347566.SGD","SG9999002232.USD","BK4559","IE00B2B36J28.USD","SG9999014898.SGD","LU1221951046.USD","SG9999018857.SGD","LU1868837300.USD","IE0034235303.USD","LU2063271972.USD","NVO.AU","LU0320765646.SGD","IE00BFTCPJ56.SGD","SG9999014906.USD","IE00BJLML261.HKD","SG9999001176.USD","LU2361045086.USD","LU0203345920.USD","LU0320765059.SGD","LU1674673691.USD","LU0234570918.USD","LU1548497426.USD","LU2089984988.USD","BK4599","IE00BGHQF631.EUR","JNJ","CDC","LU0795875086.SGD","LU1127390331.HKD","SG9999014880.SGD","LU2468319806.SGD","LU0094547139.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU1506573853.SGD"],"gpt_icon":1},{"id":"2517430667","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430667","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517430667?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:14","pubTimestamp":1741364099,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.62% to 1,443.18 on the S&P Europe Select ADR Index, which is up 0.36% for the week","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","LU0154236417.USD","EDAP","BK4107","LU0029864427.USD","BDRX","BK4011","NVO.AU","CLLS","IE00BFMHRM44.USD","LU0109394709.USD","LU1019634622.SGD","LU1267930573.SGD","BK4117","AFG","ASND","CRH","VOD","BK7104","BK4142","LU0238689110.USD","AUTL","CUK","LU0889565916.HKD","LU0128525929.USD","LU0310800379.SGD","AKTX","BK4009","CRTO","EQNR","BK4007","BK4588","LU2041044095.USD","BK4082","ARBK","LU1863844665.USD","LU2298321311.HKD","SLN","LU1880398554.USD","LU0868494708.USD","LU1291149836.SGD","BK4132","BK4139","BK4599","IE00BZ1G4Q59.USD","LU1880398471.USD","ARGX","LU1506573853.SGD","OPRA"],"gpt_icon":1},{"id":"2517118317","title":"Sector Update: Health Care Stocks Softer Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2517118317","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517118317?lang=en_us&edition=fundamental","pubTime":"2025-03-07 04:58","pubTimestamp":1741294726,"startTime":"0","endTime":"0","summary":"Health care stocks declined late Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each shedding 0.3%.The iShares Biotechnology ETF  decreased 0.4%.In corporate news, Kestra Medical Technologies  stock jumped 30% in their debut on the Nasdaq after the company priced its IPO of 11.9 million shares at $17 apiece.Eli Lilly's  weight-loss and diabetes drugs, Zepbound and Mounjaro, cannot be replicated by compounding pharmacies as a US federal judge upheld a decision by the US Food and Drug Administration last year, Reuters reported, citing the ruling. Eli Lilly shares 1.9%.Novo Nordisk  Chief Executive Officer Lars Fruergaard Jorgensen said the company will feel the impact of President Donald Trump's threatened tariffs despite its investments in the US, according to media reports. Novo shares declined 3.2%.Plus Therapeutics  shares quadrupled after the company's Rhenium obisbemeda radiotherapy, intended to treat leptomeningeal metastases in lun","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0943347566.SGD","NVO","LU2063271972.USD","IBB","IE00BK4W5M84.HKD","LU0154236417.USD","LU1127390331.HKD","XLV","LU2237443465.HKD","KMTS","BK7104","LU1720051108.HKD","LU1814569148.SGD","LU2491050154.USD","IE00BJLML261.HKD","LU0096364046.USD","LU0109391861.USD","LU1551013425.SGD","SG9999015978.USD","LU0456855351.SGD","LU0672654240.SGD","BK4588","BK4532","LU1093756168.USD","LU2468319806.SGD","LU1868836914.USD","LU0256863811.USD","NVO.AU","LU2089984988.USD","LU1917777945.USD","PSTV","LU1868837136.USD","BK4581","IE00BZ1G4Q59.USD","LU1280957306.USD","LU2361045086.USD","LU0471298694.HKD","LU0203202063.USD","LU2237443382.USD","SG9999018865.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0882574139.USD","LU1548497426.USD","SGXZ57979304.SGD","LLY","LU2237438978.USD","IE00BJT1NW94.SGD","LU1868836591.USD","LU1989771016.USD"],"gpt_icon":1},{"id":"2517191344","title":"Sector Update: Health Care Stocks Retreat Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2517191344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517191344?lang=en_us&edition=fundamental","pubTime":"2025-03-07 02:54","pubTimestamp":1741287256,"startTime":"0","endTime":"0","summary":"Health care stocks declined Thursday afternoon with the NYSE Health Care Index shedding 0.7% and the Health Care Select Sector SPDR Fund  falling 1.2%.The iShares Biotechnology ETF  dropped 1%.In corporate news, Novo Nordisk  Chief Executive Officer Lars Fruergaard Jorgensen said the company will feel the impact of President Donald Trump's threatened tariffs despite its investments in the US, according to media reports. Novo shares declined 3.4%.Plus Therapeutics  shares surged 98% after it said Thursday that its Rhenium obisbemeda radiotherapy has been granted orphan drug designation by the US Food and Drug Administration for treating leptomeningeal metastases in lung cancer patients.BridgeBio Pharma  shares were falling past 6% after KKR Genetic Disorder disclosed the sale of 6 million BridgeBio shares in a regulatory filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","BK4505","PSTV","LU1093756325.SGD","BK4139","NVO.AU","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IBB","BK4588","BK4007","BK7104","BK4599","NVO","BK4581","BK4532","BBIO","XLV","BK4585"],"gpt_icon":1},{"id":"2517316249","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2517316249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517316249?lang=en_us&edition=fundamental","pubTime":"2025-03-07 00:12","pubTimestamp":1741277533,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.61% to 1,444.24 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by Sequans Communications  and financial services company ING Groep , which rose 6.8% and 4.2% respectively. They were followed by financial services company Banco Santander  and biopharmaceutical company Genfit , which were up 2.2% each.The decliners from continental Europe were led by furniture maker Natuzzi  and pharmaceutical company Novo Nordisk , which fell 3.7% and 2.1% respectively. They were followed by biotech firm BioNTech  and biopharmaceutical company Cellectis , which lost 1.9% and 1.3% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm  and Akari Therapeutics , which advanced 16.7% and 8.8% respectively. They were followed by communications company WPP  and biopharmaceutical company Verona Pharma , which i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7141","PSO","ADAP","BK4111","ING","BK4207","AFG","BK4551","SAN.AU","BK4141","BK4107","BK7505","SQNS","BK4599","BK4568","BK7104","NTZ","BK4095","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4117","AKTX","WPP","BK4139","BNTX","WPP.AU","BK4007","TCBP","BK7142","GNFT","NVO","BK4204","BK4532","BK4585","CUK","LU1093756168.USD","IHG","BK4548","BK4588","LU1093756325.SGD","CLLS","BK4521","VRNA","BK4009","SAN","ING.AU","BK4535","BK4142","NVO.AU","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2517928707","title":"Sector Update: Health Care Stocks Higher in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517928707?lang=en_us&edition=fundamental","pubTime":"2025-03-06 02:54","pubTimestamp":1741200858,"startTime":"0","endTime":"0","summary":"Health care stocks were rising Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each adding 0.6%.The iShares Biotechnology ETF  added 1.1%.In corporate news, Novo Nordisk  said it launched a direct-to-patient delivery option that offers patients all dose strengths of Wegovy at a reduced cost. Novo shares gained 3.4%.Amgen  has started two phase 3 trials for its obesity drug MariTide, the company's Head of Research and Development, Jay Bradner, said Wednesday at an investor conference. Amgen shares rose 1.4%.Merck  is facing a patent dispute that threatens its plans to sell a new version of Keytruda, its top-selling cancer drug, the Wall Street Journal reported. Merck shares were fractionally higher.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","LU1037948541.HKD","IE00BKVL7J92.USD","LU1066053197.SGD","AMGN","LU2461242641.AUD","SG9999015341.SGD","LU0320765646.SGD","IE0002141913.USD","LU1066051498.USD","IE00BLSP4452.SGD","IE00B2B36J28.USD","LU0154236417.USD","LU1934455277.USD","LU1989772923.USD","BK4599","MRK","SG9999002232.USD","BK4534","LU2089984988.USD","LU0109394709.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU0266013472.USD","LU1116320737.USD","SG9999014559.SGD","LU1057294990.SGD","LU1430594728.SGD","BK4559","LU1162221912.USD","LU0868494617.USD","BK4588","LU2112291526.USD","LU2361044949.HKD","NVO","IE00BLSP4239.USD","LU0889565916.HKD","IBB","BK4581","LU1571399168.USD","LU1699723380.USD","NVO.AU","SG9999014542.SGD","LU0965508806.USD","XLV","LU0006306889.USD","LU0289739699.SGD","LU0320765992.SGD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2517945267","title":"Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2517945267","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517945267?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:51","pubTimestamp":1741186306,"startTime":"0","endTime":"0","summary":"Novo Nordisk slashed the price of Wegovy by more than half on Wednesday amid a bitter rivalry with Hims & Hers Health.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/novo-nordisk-wegovy-price-cut-hims-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU0154236417.USD","BK4532","LU1093756325.SGD","NVO.AU","IE00BZ1G4Q59.USD","HIMS","BK7104","BK4588","IE00BKVL7J92.USD","BK4196","LU1093756168.USD","BK4007","BK4585","BK4599","NVO"],"gpt_icon":1},{"id":"2517891465","title":"Novo Nordisk Launches Delivery Option Offering Lower-Priced Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517891465","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517891465?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:29","pubTimestamp":1741181366,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Wednesday it is offering cash-paying patients all dose strengths of Wegovy at a lower price of $499 per month through a direct-to-patient delivery option called NovoCare Pharmacy.The company said NovoCare Pharmacy expands its offerings to meet the needs of people living with obesity, following the recent decision of the US Food and Drug Administration that the shortage of the medicine has been resolved.Uninsured patients or eligible patients with commercial insurance who don't have coverage for obesity medicines can avail of the offer, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756168.USD","NVO.AU","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","BK7104","BK4585","BK4588","BK4599","BK4007","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":149,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVO.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVO.AU\",market:\"AU\",,,undefined,":[]}}